Relapses in multiple sclerosis are associated with increased CD8+ T-cell mediated cytotoxicity in CSF

被引:54
|
作者
Malmestrom, Clas [2 ]
Lycke, Jan [2 ]
Haghighi, Sara [2 ]
Andersen, Oluf [2 ]
Carlsson, Lena [1 ]
Wadenvik, Hans [1 ]
Olsson, Bob [1 ]
机构
[1] Univ Gothenburg, Sahlgrens Univ Hosp, Dept Internal Med, Sahlgrenska Acad, SE-41345 Gothenburg, Sweden
[2] Univ Gothenburg, Sahlgrens Univ Hosp, Sahlgrenska Acad, Dept Neurol, SE-41345 Gothenburg, Sweden
关键词
multiple sclerosis; T-cells; T-cell mediated cytotoxicity; microarray; granzymes;
D O I
10.1016/j.jneuroim.2008.03.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
MS is thought to be mediated by CD4(+) T-helper cells. To investigate the importance of CD8(+) cytotoxic T-cells in MS we analyzed peripheral blood T-cells by DNA microarray, and plasma and CSF levels of granzymes from MS patients and controls. Cytotoxic gene expression was decreased in peripheral T-cells from RRMS patients whereas plasma levels of granzymes were unchanged. However, granzyme levels were elevated in the, CSF of RRMS patients at relapse compared with controls and remission. Thus, CD8+ T-cell-mediated cytotoxicity is confined to the CSF/CNS compartment in RRMS patients and may be involved in the immunopathogenesis of clinical relapses. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:159 / 165
页数:7
相关论文
共 50 条
  • [1] Relapses in multiple sclerosis are associated with increased CD8+T-cell cytotoxicity in CSF
    Malmestrom, C.
    Lycke, J.
    Haghighi, S.
    Andersen, O.
    Carlsson, L.
    Wadenvik, H.
    Olsson, B.
    MULTIPLE SCLEROSIS JOURNAL, 2007, 13 : S37 - S37
  • [2] Increased CD8+ T cell responses to apoptotic T cell-associated antigens in multiple sclerosis
    Lolli, Francesco
    Martini, Helene
    Citro, Alessandra
    Franceschini, Debora
    Portaccio, Emilio
    Amato, Maria Pia
    Mechelli, Rosella
    Annibali, Viviana
    Sidney, John
    Sette, Alessandro
    Salvetti, Marco
    Barnaba, Vincenzo
    JOURNAL OF NEUROINFLAMMATION, 2013, 10
  • [3] Increased CD8+ T cell responses to apoptotic T cell-associated antigens in multiple sclerosis
    Francesco Lolli
    Helene Martini
    Alessandra Citro
    Debora Franceschini
    Emilio Portaccio
    Maria Pia Amato
    Rosella Mechelli
    Viviana Annibali
    John Sidney
    Alessandro Sette
    Marco Salvetti
    Vincenzo Barnaba
    Journal of Neuroinflammation, 10
  • [4] Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis
    Zang, YCQ
    Li, SF
    Rivera, VM
    Hong, B
    Robinson, RR
    Breitbach, WT
    Killian, J
    Zhang, JZ
    JOURNAL OF IMMUNOLOGY, 2004, 172 (08): : 5120 - 5127
  • [5] INHIBITION OF T-CELL MEDIATED CYTOTOXICITY BY NOVOBIOCIN SUGGESTS MULTIPLE PATHWAYS FOR BOTH CD4+ AND CD8+ CYTOTOXIC T-CELLS
    WOOD, PJ
    STANSFIELD, AG
    IMMUNOLOGY, 1992, 76 (03) : 460 - 464
  • [6] CD8+ T cells in multiple sclerosis
    Denic, Aleksandar
    Wootla, Bharath
    Rodriguez, Moses
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2013, 17 (09) : 1053 - 1066
  • [7] CSF enrichment of highly differentiated CD8+ T cells in early multiple sclerosis
    Jilek, Samantha
    Schluep, Myriam
    Rossetti, Andrea O.
    Guignard, Laurence
    Le Goff, Geraldine
    Pantaleo, Giuseppe
    Du Pasquier, Renaud A.
    CLINICAL IMMUNOLOGY, 2007, 123 (01) : 105 - 113
  • [8] Increased CD8+ central memory T cells in patients with multiple sclerosis
    Liu, Guang-Zhi
    Fang, Li-Bo
    Hjelmstrom, Peter
    Gao, Xu-Guang
    MULTIPLE SCLEROSIS JOURNAL, 2007, 13 (02) : 149 - 155
  • [9] Interferon-β therapy reduces CD4+ and CD8+ T-cell reactivity in multiple sclerosis
    Zafranskaya, Marina
    Oschmann, Patrick
    Engel, Rosel
    Weishaupt, Andreas
    van Noort, Johannes M.
    Jomaa, Hassan
    Eberl, Matthias
    IMMUNOLOGY, 2007, 121 (01) : 29 - 39
  • [10] Cytotoxicity is mandatory for CD8+ T cell-mediated contact hypersensitivity
    Kehren, J
    Desvignes, C
    Krasteva, M
    Ducluzeau, MT
    Assossou, O
    Horand, F
    Hahne, M
    Kägi, D
    Kaiserlian, D
    Nicolas, JF
    JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (05): : 779 - 786